Mesalamine
NDC 0378-1375, mesalamine, capsule, extended release, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-1375
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207271
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-1375 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE.375 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-1375-78 | 00378137578 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-1375-78) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c8b93ea3-0367-4605-b87f-06c3812ff3b7NADAC price for package 00378137578
GET /v1/drugs/nadac/00378137578
Use it
Look up 0378-1375 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-1375 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-1375. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.